• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤位置对上尿路移行细胞癌预后的影响。

The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract.

作者信息

Park Sungchan, Hong Bumsik, Kim Choung-Soo, Ahn Hanjong

机构信息

Department of Urology, Ulsan University College of Medicine, Asan Medical Center, Seoul, Korea.

出版信息

J Urol. 2004 Feb;171(2 Pt 1):621-5. doi: 10.1097/01.ju.0000107767.56680.f7.

DOI:10.1097/01.ju.0000107767.56680.f7
PMID:14713773
Abstract

PURPOSE

We assessed the impact of traditional prognostic factors and tumor location on the survival of patients treated for upper tract transitional cell carcinoma (TCC).

MATERIALS AND METHODS

We retrospectively analyzed the data on 86 patients with upper tract TCC who underwent nephroureterectomy with a bladder cuff (95%) or parenchymal sparing surgery (5%). Mean patient age was 59.5 years and median followup was 43.8 months. The influence of traditional prognostic factors such as age, gender, tumor stage, grade and location on 5-year disease specific and recurrence-free (local recurrence or distant metastasis) survival rates was analyzed. The difference in survival rates between renal 45 pelvis and 41 ureteral cases was analyzed according to the respective T stage and grade.

RESULTS

Overall 5-year disease specific and recurrence-free survival rates were 83% and 72%, respectively. The significant prognostic factors for survival rates by univariate analysis were T stage, grade and location. N stage was significant for 5-year recurrence-free survival. On multivariate analysis tumor location was the only independent prognostic factor for the 2 survival rates, while N stage was significant for 5-year recurrence-free survival. Patients with ureteral tumor had a worse prognosis than those with pelvis tumor at the same stage or grade (p = 0.036).

CONCLUSIONS

Pelvis and ureteral TCC are not the same disease in terms of invasion and prognosis. Ureteral TCC is associated with a higher local or distant failure rate than renal pelvis TCC. A radical surgical approach including meticulous lymphadenectomy may be therapeutic in patients with invasive ureteral TCC.

摘要

目的

我们评估了传统预后因素及肿瘤位置对上尿路移行细胞癌(TCC)患者生存情况的影响。

材料与方法

我们回顾性分析了86例接受肾输尿管膀胱袖状切除术(95%)或保留肾实质手术(5%)的上尿路TCC患者的数据。患者平均年龄为59.5岁,中位随访时间为43.8个月。分析了年龄、性别、肿瘤分期、分级及位置等传统预后因素对5年疾病特异性生存率及无复发生存率(局部复发或远处转移)的影响。根据各自的T分期和分级分析了45例肾盂病例与41例输尿管病例生存率的差异。

结果

总体5年疾病特异性生存率和无复发生存率分别为83%和72%。单因素分析显示,生存率的显著预后因素为T分期、分级及位置。N分期对5年无复发生存率有显著影响。多因素分析显示,肿瘤位置是这两种生存率的唯一独立预后因素,而N分期对5年无复发生存率有显著影响。相同分期或分级的输尿管肿瘤患者比肾盂肿瘤患者预后更差(p = 0.036)。

结论

肾盂和输尿管TCC在侵袭性和预后方面并非同一种疾病。输尿管TCC比肾盂TCC的局部或远处失败率更高。对于侵袭性输尿管TCC患者,包括细致淋巴结清扫的根治性手术方法可能具有治疗作用。

相似文献

1
The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract.肿瘤位置对上尿路移行细胞癌预后的影响。
J Urol. 2004 Feb;171(2 Pt 1):621-5. doi: 10.1097/01.ju.0000107767.56680.f7.
2
Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.上尿路移行细胞癌中淋巴管侵犯的预后价值
Urology. 2005 Apr;65(4):692-6. doi: 10.1016/j.urology.2004.11.001.
3
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.原发性肿瘤的位置并非上尿路尿路上皮癌患者癌症特异性死亡率的独立预测因素。
J Urol. 2009 Nov;182(5):2177-81. doi: 10.1016/j.juro.2009.07.035. Epub 2009 Sep 16.
4
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.上尿路移行细胞癌的预后因素、复发及生存情况:252例患者的30年经验
Urology. 1998 Oct;52(4):594-601. doi: 10.1016/s0090-4295(98)00295-7.
5
Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.在接受根治性肾输尿管切除术治疗局限性上尿路上皮细胞癌的患者中,淋巴血管侵犯和 pT 分期是预后因素。
Urology. 2010 Feb;75(2):328-32. doi: 10.1016/j.urology.2009.07.1350.
6
The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.pT3期上尿路移行细胞癌患者预后的影响因素
J Urol. 2007 Aug;178(2):446-50, dicussion 450. doi: 10.1016/j.juro.2007.03.115. Epub 2007 Jun 11.
7
Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.膀胱肿瘤病史及肿瘤位置在上尿路移行细胞癌中的预后意义
J Urol. 2006 Jul;176(1):48-52. doi: 10.1016/S0022-5347(06)00511-8.
8
The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.肾实质作为上尿路移行细胞癌局部肿瘤扩散屏障的保护作用及其对患者生存的影响。
J Urol. 2009 Sep;182(3):894-9. doi: 10.1016/j.juro.2009.05.040. Epub 2009 Jul 17.
9
Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?26例上尿路浸润性移行细胞癌患者的术后放射治疗:对生存无影响?
J Urol. 1996 Jan;155(1):115-7.
10
Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.机器人辅助腹腔镜肾输尿管切除术联合膀胱袖口切除术治疗上尿路尿路上皮癌后的肿瘤学结局
J Urol. 2015 Dec;194(6):1561-6. doi: 10.1016/j.juro.2015.07.081. Epub 2015 Jul 17.

引用本文的文献

1
Correlation between the timing of diagnostic ureteroscopy for upper tract urothelial cancer and intravesical recurrence after radical nephroureterectomy.上尿路尿路上皮癌诊断性输尿管镜检查时机与根治性肾输尿管切除术后膀胱内复发的相关性
Front Oncol. 2023 Mar 22;13:1122877. doi: 10.3389/fonc.2023.1122877. eCollection 2023.
2
Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis.输尿管肿瘤与肾盂肾盏肿瘤患者的生存差异:一项系统评价和荟萃分析。
Arch Med Sci. 2019 Nov 21;17(3):603-612. doi: 10.5114/aoms.2019.89893. eCollection 2021.
3
Lynch Syndrome: Its Impact on Urothelial Carcinoma.
林奇综合征:对尿路上皮癌的影响。
Int J Mol Sci. 2021 Jan 7;22(2):531. doi: 10.3390/ijms22020531.
4
Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.肾输尿管切除术治疗上尿路上皮癌后局部复发的模式和危险因素。
World J Surg Oncol. 2020 May 30;18(1):114. doi: 10.1186/s12957-020-01877-w.
5
Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma.鳞状分化对上尿路尿路上皮癌患者膀胱内复发及预后的影响。
Ann Transl Med. 2019 Aug;7(16):377. doi: 10.21037/atm.2019.07.31.
6
Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.上尿路尿路上皮癌:术前脓尿与膀胱癌复发和生存无关。
Int Urol Nephrol. 2019 May;51(5):831-838. doi: 10.1007/s11255-019-02133-1. Epub 2019 Apr 1.
7
Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?原发性和继发性上尿路尿路上皮癌肿瘤之间存在差异吗?
Can Urol Assoc J. 2019 Sep;13(9):E292-E299. doi: 10.5489/cuaj.5595.
8
Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients.上尿路尿路上皮癌手术治疗后肌肉浸润性膀胱癌和尿道癌复发:305例患者的回顾性研究
Turk J Urol. 2018 May;44(3):213-220. doi: 10.5152/tud.2018.19677. Epub 2018 Mar 6.
9
Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy.肾输尿管切除术后上尿路尿路上皮癌肿瘤大小和位置对生存的影响。
Indian J Urol. 2018 Jan-Mar;34(1):68-73. doi: 10.4103/iju.IJU_216_17.
10
Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract.膀胱及上尿路尿路上皮癌的分子特征
Transl Oncol. 2018 Feb;11(1):37-42. doi: 10.1016/j.tranon.2017.10.008. Epub 2017 Nov 21.